Home›Research›Compare›ARA-290 vs HLDF-6
Peptide Comparison
ARA-290 vs HLDF-6
Both are Longevity peptides.
HLDF-6
Human Leukemia Differentiation Factor 6
No providers listed yet
Quick Verdict
ARA-290
Risk
Half-life
~3 hours
HLDF-6
Risk
Half-life
—
Side-by-Side Comparison
About ARA-290
Non-hematopoietic EPO analogue; activates innate repair receptor (IRR/EPOR/CD131 complex) without erythropoietic effects; promotes tissue repair and nerve healing
A modified erythropoietin peptide that activates tissue repair pathways without stimulating red blood cell production. Strong evidence for neuropathic pain and sarcoidosis.
Research Areas
About HLDF-6
Modulates cholinergic neurotransmission. Reduces amyloid-β toxicity and protects against oxidative stress-induced neuronal damage. May enhance memory consolidation via acetylcholine pathway upregulation.
A hexapeptide fragment of Human Leukemia Differentiation Factor with neuroprotective and memory-enhancing properties identified primarily in Russian academic research. Studied for cognitive decline associated with aging and Alzheimer's-like pathology.
Research Areas
Find Providers
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More longevity Comparisons
Browse all peptides →Educational research tools — not medical advice.